Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BETAMETHASONE DIPROPIONATE\CALCIPOTRIENE for Pustular psoriasis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where BETAMETHASONE DIPROPIONATE\CALCIPOTRIENE was used for Pustular psoriasis.

Most Reported Side Effects for BETAMETHASONE DIPROPIONATE\CALCIPOTRIENE

Side Effect Reports % Deaths Hosp.
Drug ineffective 120 19.5% 0 8
Psoriasis 101 16.4% 0 9
Pruritus 45 7.3% 0 0
Inappropriate schedule of drug administration 40 6.5% 0 3
Product use issue 39 6.3% 0 14
Medication residue present 35 5.7% 0 0
Alopecia 31 5.0% 0 6
Diarrhoea 30 4.9% 0 0
Condition aggravated 29 4.7% 0 1
Psoriatic arthropathy 29 4.7% 0 0
Rash 29 4.7% 0 5
Burning sensation 27 4.4% 0 0
Covid-19 27 4.4% 0 0
Mouth ulceration 26 4.2% 0 0
Therapeutic product effect incomplete 26 4.2% 0 2

Other Indications for BETAMETHASONE DIPROPIONATE\CALCIPOTRIENE

Psoriasis (386) Product used for unknown indication (145) Dermatitis atopic (7) Psoriatic arthropathy (7) Benign familial pemphigus (5)

Other Drugs Used for Pustular psoriasis

APREMILAST (349) SECUKINUMAB (317) ADALIMUMAB (207) METHOTREXATE (159) CYCLOSPORINE (157) ETANERCEPT (146) INFLIXIMAB (144) ACITRETIN (129) USTEKINUMAB (120) EFALIZUMAB (101)

Related Pages

BETAMETHASONE DIPROPIONATE\CALCIPOTRIENE Full Profile All Pustular psoriasis Drugs BETAMETHASONE DIPROPIONATE\CALCIPOTRIENE Demographics BETAMETHASONE DIPROPIONATE\CALCIPOTRIENE Timeline